Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.29 USD | +2.08% | -13.38% | -25.68% |
04-11 | Zentalis Pharmaceuticals, Inc. Announces Executive Changes | CI |
04-11 | Zentalis Pharmaceuticals, Inc. Announces CFO Changes | CI |
Sales 2024 * | 7M 9.56M | Sales 2025 * | 4.28M 5.85M | Capitalization | 785M 1.07B |
---|---|---|---|---|---|
Net income 2024 * | -270M -369M | Net income 2025 * | -305M -416M | EV / Sales 2024 * | 55.8 x |
Net cash position 2024 * | 394M 538M | Net cash position 2025 * | 340M 464M | EV / Sales 2025 * | 104 x |
P/E ratio 2024 * |
-3.04
x | P/E ratio 2025 * |
-2.93
x | Employees | 124 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.73% |
Latest transcript on Zentalis Pharmaceuticals, Inc.
1 day | +2.08% | ||
1 week | -13.38% | ||
Current month | -28.55% | ||
1 month | -30.19% | ||
3 months | -14.44% | ||
6 months | -29.62% | ||
Current year | -25.68% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 20-06-30 | |
Cam Gallagher
FOU | Founder | 54 | 14-12-22 |
Mark Lackner
CTO | Chief Tech/Sci/R&D Officer | 56 | 22-10-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cam Gallagher
FOU | Founder | 54 | 14-12-22 |
Diana Hausman
CTO | Chief Tech/Sci/R&D Officer | 61 | 23-05-07 |
Karan Takhar
BRD | Director/Board Member | 32 | 17-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.11% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | 0.00% | - | |
0.07% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 11.26 | +1.81% | 158 096 |
24-04-26 | 11.06 | +0.68% | 474,113 |
24-04-25 | 10.98 | -6.67% | 1,077,726 |
24-04-24 | 11.77 | -6.36% | 854,473 |
24-04-23 | 12.57 | -3.31% | 379,793 |
Delayed Quote Nasdaq, April 29, 2024 at 01:45 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.68% | 785M | |
-2.56% | 103B | |
+1.76% | 95.28B | |
+1.46% | 22.15B | |
-15.71% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.71% | 16.05B | |
+5.65% | 13.68B | |
+34.44% | 12.17B |
- Stock Market
- Equities
- ZNTL Stock